Disease

Coverage of infectious and chronic diseases — their causes, mechanisms, epidemiology, prevention strategies, and the latest science on how the body fights back.

Here is a graphic of vaccine’s economic value. It has a huge multiplier for the most concrete of benefits, reducing the number of individuals that require treatment - $16 saved for each $1 spent.
The EPA defines environmental injustice as a  “disproportionate share of negative consequences resulting from industrial, municipal, or commercial operations.” 
The study looks at hospitalized patients predominantly in the US along with Spain, China, and South Korea. The roughly 300,000 patients received a combination of 3455 different repurposed and adjunctive drugs.
Obesity is a description, not a “disease.”
The media took an optimistic assessment of the current situation, but new cases remain far worse than when the pandemic began in March of 2020 or at the subsequent low point in June.
This will mark the fourth article in a little over a week on ivermectin on our website, and we are not alone.
Dr. Dan Stein recently presented a dataset representing an ongoing meta-analysis of patients' responses with COVID-19 to ivermectin.
Why can’t a drug approved and used in humans for 35 years, with excellent safety margins, and 3.7 billion doses administered worldwide, and with almost uniformly demonstrated benefit in all stages of COVID-19 infection, get a decent day in court?&
The COVID-19 pandemic has spurred a new level of interest in lung health.